Replay available

Rapid Micro Biosystems, Inc. (RPID) Q2 2026 Earnings Call

Rapid Micro Biosystems, Inc. (NASDAQ: RPID) Q2 2026 earnings conference call, held 2026-08-07. Replay captured from the company's public earnings webcast.

Fri, August 7, 2026 at 8:30 AMendedReplay
Rapid Micro Biosystems, Inc. (RPID) Q2 2026 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Mike Beaulieu

Investor Relations

Rob Spignesi

President and Chief Executive Officer

Sean Wirtjes

Chief Financial Officer

Thomas Flatton

Analyst, Lake Street Capital Markets

Dan Arias

Analyst, Stiefel

Brendan Smith

Analyst, TD Cowan

Anna Snupkowski

Analyst, KeyBank

Replay transcript excerpt

Good day and thank you for standing by. Welcome to the Rapid Micro Biosystems second quarter 2026 earnings conference call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question and answer session. To ask a question during this session, you will need to press star 1-1 on your telephone. You will then hear an automated message advising your hand is raised. To withdraw your question, please press star 1-1 again. Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker today, Mike Beaulieu with Investor Relations. Please go ahead, sir. Good morning, and thank you for joining the Rapid Micro Biosystems second quarter earnings call. Joining me on the call are Rob Spignesi, President and Chief Executive Officer, and Sean Wirtjes, Chief Financial Officer. This morning, we issued a press release announcing our second quarter results. A copy of the release is available on the company's website at rapidmicrobio.com. under Investors in the News and Events section. Before we begin, I'd like to remind you that many statements made during this call may be considered forward-looking statements within the meaning of federal securities laws, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Any statements contained in this call that relate to expectations or predictions of future events, results, or performance are forward-looking statements, including but not limited to statements relating to Rapid Micro's financial condition, Assumptions regarding future financial performance Anticipated future cash usage Statements relating to the company's term loan facility Guidance for 2026, including revenue...

More from Rapid Micro Biosystems, Inc.